Relations of the Congestive Cardiac Failure with Troponin I and CK-MB

Basit Öğe Kaydı
dc.authoridOguzturk, Hakan/0000-0002-9800-1428
dc.authoridTurtay, Muhammet Gokhan/0000-0002-1728-8237
dc.authorwosidOguzturk, Hakan/AAC-3915-2021
dc.authorwosidoguzturk, hakan/Q-6242-2019
dc.authorwosidTurtay, Muhammet Gokhan/ABG-7401-2020
dc.contributor.authorTopal, Fatih Esat
dc.contributor.authorOguzturk, Hakan
dc.contributor.authorTopal, Firdevs
dc.contributor.authorYildirim, Birdal
dc.contributor.authorGokhan, Muhammet
dc.date.accessioned2024-08-04T20:35:47Z
dc.date.available2024-08-04T20:35:47Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe cardiac failure is a disease of a significant increase in incidence within the last two decades. In Turkey, like many other countries, the cardiac failure is the main reason of many deaths. In this study, the major structural characteristic of Congestive Cardiac Failure (CCF) is the myocardial cell death, and therefore the authors preferred to research the relation between the troponin I and cardiac CK-MB that are specific proteins for the cardiac necrosis. Methods: In this study, the Troponin I and CK-MB levels were checked in 75 patients of congestive cardiac failure and a control group. The control group comprises of 60 people of comparable ages and genders with no cardiovascular or other diseases. While the ejective fraction was lower than 50% in all the 75 patients, it was over 50% in all individuals of the control group. Results: The troponin I and CK-MB levels of the patient group were observed to be significantly higher in comparison with the control group. Furthermore, based on NYFIA, the troponin I and CK-MB levels in the class III and IV patient groups were significantly higher than the levels of the class I and II groups. Conclusion the congestive cardiac failure patients have significantly higher troponin I and CK-MB levels. The cardiac troponin I and CK-MB levels may be an appropriate and cost effective scanning test for such patients. It may however be useful to use such parameters in classification of the advanced level cardiac failure morbidity, mortality and short-long term prognosis.en_US
dc.identifier.endpage647en_US
dc.identifier.issn1840-2291
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-84857745090en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage643en_US
dc.identifier.urihttps://hdl.handle.net/11616/95587
dc.identifier.volume6en_US
dc.identifier.wosWOS:000301754800046en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherDrunpp-Sarajevoen_US
dc.relation.ispartofHealthmeden_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCardiac Failureen_US
dc.subjectTroponin Ien_US
dc.subjectCK-MBen_US
dc.subjectVentricular Ejection Fractionen_US
dc.titleRelations of the Congestive Cardiac Failure with Troponin I and CK-MBen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu